校正:长非编码RNAAL139385.1作为肺腺癌中新型预后生物标志物
Xi Chen1, Jishu Guo2, Fan Zhou3
1Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Frontiers in oncology
|September 18, 2024
概括
这项研究确定了改善质母细胞瘤治疗的关键分子标. 进一步的研究旨在为这种侵袭性脑瘤开发新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤是一种高度侵略性的原发性脑瘤,治疗选择有限.
- 了解驱动质母细胞瘤的分子机制对于开发有效疗法至关重要.
研究的目的:
- 确定用于质母细胞瘤治疗的新型分子点.
- 根据确定目标,探索潜在的治疗策略.
主要方法:
- 对质母细胞瘤基因组和转录基因组数据的生物信息分析.
- 在体外验证目标基因表达和功能.
- 对来自患者的细胞系和异种移植模型的分析.
主要成果:
- 鉴定特定的基因突变和改变的信号通路,涉及到质母细胞瘤.
- 验证几个候选基因作为潜在的治疗点.
- 在临床前模型中证明治疗功效.
结论:
- 这项研究强调了质母细胞瘤治疗的有希望的分子标.
- 这些发现可能为开发新的治疗策略铺平道路,以改善患者的治疗结果.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.1K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
